Your session is about to expire
← Back to Search
Stem Cell Therapy
Bone Marrow Derived Stem Cells for Skin Aging
Phase 1 & 2
Waitlist Available
Research Sponsored by Stemedica Cell Technologies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Males and Females 40-70 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trialexplores if an injection of bone marrow cells can help heal facial skin damaged by sunlight.
Who is the study for?
This trial is for men and women aged 40-70 with moderate to deep wrinkles, who are in good health and have a skin type I-III. They must not have had facial cosmetic treatments or cancer within the past 5 years, no stem cell treatments before, and can't be using anti-aging creams during the study.Check my eligibility
What is being tested?
The study tests if a one-time injection of allogeneic mesenchymal bone marrow cells is safe and effective for treating signs of aging on the face caused by sun exposure.See study design
What are the potential side effects?
Potential side effects may include reactions at the injection site, such as redness or swelling. Since it's a safety study, other unexpected side effects related to immune response might also be monitored.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 40 and 70 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
MSC Safety and Tolerability
Secondary outcome measures
MSC Efficacy
Trial Design
1Treatment groups
Experimental Treatment
Group I: Allogeneic Mesenchymal Bone Marrow CellsExperimental Treatment1 Intervention
1550 nm Fraxel laser treatment (6-8 mJ, Level 2) to full face followed by IV infusion of Allogeneic Mesenchymal Bone Marrow Cells (0.5, 1.0, or 1.5 million cells/kg, up to 150 million cells)
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Stemedica Cell Technologies, Inc.Lead Sponsor
5 Previous Clinical Trials
141 Total Patients Enrolled
Lev Verkh, PhDStudy DirectorStemedica Cell Technologies, Inc.
2 Previous Clinical Trials
78 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My organs are working well.I am using effective birth control and will continue for 13 months.I have a history of melanoma, leukemia, or lymphoma.I have ongoing skin conditions that could turn into cancer.I have a skin infection on my head or neck.I agree to stop using anti-aging creams on my head or neck for a year.I have not had cancer or been in late-stage cancer in the last 5 years.I have previously received stem cell treatment.My recent chest CT scan showed abnormal findings.I haven't had any cosmetic or surgical treatments on my face/neck in the last 6 months.I am not pregnant, breastfeeding, or planning to become pregnant during the study.I have not had major surgery in the last 4 weeks.I am between 40 and 70 years old.I have a skin cancer in the area that would be treated.
Research Study Groups:
This trial has the following groups:- Group 1: Allogeneic Mesenchymal Bone Marrow Cells
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the age cutoff for participation in this trial under 70 years?
"According to the inclusion criteria, qualified applicants for this research project must be between 40 and 70 years old. If a participant falls outside of these age limits, there are 14 studies specifically targeting those below 18 or 37 trials catered towards those above 65."
Answered by AI
Could potential participants still join this research endeavor?
"According to the data available on clinicaltrials.gov, this investigation is not presently looking for participants. This trial was initially posted on July 1st 2015 and last modified October 27th 2022; however, 45 other studies are actively enrolling new volunteers at this time."
Answered by AI
What are the qualifications for taking part in this investigation?
"Patients aged 40-70 with dermatologic disorders can apply to enter this clinical study, for which the team is seeking 29 participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger